244 related articles for article (PubMed ID: 12077735)
21. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients.
Hauser AC; Hagen W; Rehak PH; Buchmayer H; Födinger M; Papagiannopoulos M; Bieglmayer C; Apsner R; Köller E; Ignatescu M; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Apr; 37(4):758-65. PubMed ID: 11273876
[TBL] [Abstract][Full Text] [Related]
23. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
25. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
[TBL] [Abstract][Full Text] [Related]
26. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
27. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.
McGregor DO; Dellow WJ; Robson RA; Lever M; George PM; Chambers ST
Kidney Int; 2002 Mar; 61(3):1040-6. PubMed ID: 11849459
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency.
Guttormsen AB; Schneede J; Ueland PM; Refsum H
Am J Clin Nutr; 1996 Feb; 63(2):194-202. PubMed ID: 8561060
[TBL] [Abstract][Full Text] [Related]
29. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
30. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects.
Herrmann W; Schorr H; Bodis M; Knapp JP; Müller A; Stein G; Geisel J
Eur J Clin Invest; 2000 Dec; 30(12):1083-9. PubMed ID: 11122323
[TBL] [Abstract][Full Text] [Related]
31. Therapy of hyperhomocysteinemia in end-stage renal disease patients.
Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G
Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441
[TBL] [Abstract][Full Text] [Related]
32. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
[TBL] [Abstract][Full Text] [Related]
33. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.
Touam M; Zingraff J; Jungers P; Chadefaux-Vekemans B; Drüeke T; Massy ZA
Kidney Int; 1999 Dec; 56(6):2292-6. PubMed ID: 10594808
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
35. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
36. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
37. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Jacques PF; Dworkin L; Selhub J
Transplantation; 2000 May; 69(10):2128-31. PubMed ID: 10852611
[TBL] [Abstract][Full Text] [Related]
38. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
[TBL] [Abstract][Full Text] [Related]
39. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
[TBL] [Abstract][Full Text] [Related]
40. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Yango A; Shemin D; Hsu N; Jacques PF; Dworkin L; Selhub J; Bostom AG
Kidney Int; 2001 Jan; 59(1):324-7. PubMed ID: 11135086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
